Farouk Barguellil | Antimicrobial Resistance | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Farouk Barguellil | Antimicrobial Resistance | Best Researcher Award

Head of Department at HMPIT, Tunisia

Professor Farouk Barguellil is a renowned expert in microbiology and clinical biology, serving as a senior figure within Tunisia’s military medical sector and academic institutions. With a career that spans over three decades, he has significantly contributed to bacteriology, virology, and the advancement of diagnostic tools in infectious diseases. As a Colonel Pharmacist Biologist in the Armed Forces and Director of the research laboratory LR19DN03, he remains actively involved in national and international health initiatives.

Profile

Google scholar

Education

Professor Barguellil began his academic journey with a Bachelor’s degree in Mathematical Sciences in 1979, followed by a graduation diploma in pharmaceutical studies in 1984. His postgraduate medical training included residency in clinical biology at Tunisian hospitals from 1985 to 1989. Further specialization in microbiology was gained through an intensive internship at Bichat Claude Bernard Hospital in France, under the mentorship of Professor Antoine Andremont, from 1996 to 1997.

Experience

His professional experience is marked by a steady progression through both military and academic ranks. Starting as a Resident and later Biologist Pharmacist in the Tunisian military health system, he served at key institutions such as the Military Hospitals of Tunis, Gabès, and Bizerte. He was promoted to Chief of Service in 2004 and later to Colonel Pharmacist Biologist in 2012. Since 2018, he has led the Microbiology Service at the Main Military Training Hospital in Tunis and became Head of the Department in 2019. In parallel, he has held pivotal university roles, teaching clinical bacteriology, virology, hospital hygiene, and microbiology to both undergraduate and postgraduate students.

Research Interest

Professor Barguellil’s research focuses on clinical microbiology, antibiotic resistance, emerging and re-emerging infectious diseases, and the molecular diagnostics of microorganisms. He leads the laboratory LR19DN03, which explores microorganism-environment interactions, and the development of molecular tools for diagnosing infections. His interdisciplinary approach bridges microbiological research with public health strategies.

Award

He has been recognized through successive promotions in military and academic ranks, culminating in his appointment as a Professor Hospital-University in Pharmacy (specializing in microbiology) in 2006. His role as Director of a national research laboratory and multiple national health committees underlines his stature in the scientific and public health communities.

Publications

Professor Barguellil has an extensive body of scientific work. Selected notable publications include:

  1. “Emergence of Carbapenemase-Producing Klebsiella pneumoniae in Tunisia,” Microbial Drug Resistance, 2022, cited by 19 articles.
  2. “Molecular Detection of ESBL Genes among E. coli Isolated from Tunisian Hospitals,” Infection, Genetics and Evolution, 2021, cited by 23 articles.
  3. “Antibiotic Resistance Patterns in Staphylococcus aureus Strains from Clinical Samples,” Journal of Infection in Developing Countries, 2020, cited by 17 articles.
  4. “Prevalence of MRSA in Military Hospitals: A Surveillance Study,” African Journal of Laboratory Medicine, 2019, cited by 15 articles.
  5. “Diagnostic Value of PCR-Based Detection of Mycobacterium tuberculosis,” Tunisian Journal of Clinical Biology, 2018, cited by 12 articles.
  6. “Evaluation of Blood Culture Systems in the Detection of Bacteremia,” Military Medicine International, 2017, cited by 9 articles.
  7. “Resistance Genes in Nosocomial Pathogens: A Molecular Analysis,” Tropical Medicine and Infectious Disease, 2016, cited by 11 articles.

Conclusion

Professor Farouk Barguellil has established himself as a leading microbiologist in Tunisia, with a legacy grounded in public health, military service, academic excellence, and diagnostic innovation. His dual role as an educator and practitioner allows him to shape the next generation of microbiologists while advancing research in microbial resistance and infection control. His numerous contributions to clinical bacteriology and his leadership in both academic and healthcare environments make him an exemplary nominee for the Best Researcher Award.

Weiwei Chen | Infectious Diseases | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Weiwei Chen | infectious diseases | Best Researcher Award

Director Technician at Fifth Medical Center of Chinese PLA General Hospital, China

Weiwei Chen is a distinguished expert in infectious disease medicine, currently serving as the Director Technician and Deputy Director of the Institute of Infectious Disease Medicine at the Fifth Medical Center of the General Hospital of the People’s Liberation Army (PLA), China. With over three decades of experience in laboratory diagnostics and infectious disease control, she has become a vital figure in China’s medical defense infrastructure. Her leadership has been instrumental in managing large-scale epidemic responses, both domestically and internationally. Through her technical guidance, scholarly output, and fieldwork, Chen has demonstrated a sustained commitment to advancing public health, medical training, and disease surveillance, making her a leading candidate for recognition in the field of infectious disease research and control.

Profile

Scopus

Education

Chen’s educational foundation is rooted in medical diagnostics and epidemiology. She earned her bachelor’s degree in Laboratory Medicine from the Third Military Medical University in 1990, providing her with core clinical and laboratory skills. Pursuing further specialization, she obtained her master’s degree in Clinical Laboratory Diagnostics from the same university in 2001, which refined her expertise in pathogen detection and diagnostic methodologies. In 2007, she completed her doctoral studies in Infectious Diseases at the Chinese PLA Medical School, focusing on disease transmission dynamics and immunological responses to viral outbreaks. This progression illustrates her enduring commitment to scientific excellence and specialized knowledge.

Experience

Over the course of her professional career, Chen has assumed numerous technical and leadership roles, culminating in her current position as Deputy Director of the Institute of Infectious Disease Medicine at the PLA’s Fifth Medical Center. She oversees pathogen surveillance, laboratory operations, and technical training programs tailored to military and civilian health contingencies. Her field experience includes serving as the head of the fifth group of the Chinese Military Medical Expert Group (CMMEG) dispatched to Sierra Leone from 2019 to 2022. Under her leadership, the group made significant contributions to local COVID-19 mitigation strategies in collaboration with the Republic of Sierra Leone Armed Forces. Her proactive involvement in epidemic control and her capacity to translate scientific research into applied medical strategies underscore her value as a national and international asset in disease prevention.

Research Interest

Chen’s research centers on the immune mechanisms and therapeutic targets associated with high-impact infectious diseases such as COVID-19, influenza, and adenovirus. She has a deep interest in understanding how viral pathogens evade immune responses and identifying potential molecular interventions. In addition to this, she investigates the mechanisms of pathogen transmission in group settings, especially in military environments, aiming to create effective strategies for outbreak prediction and containment. Her work seamlessly integrates laboratory diagnostics, immunology, and field epidemiology to develop evidence-based responses to emerging public health threats.

Award

Weiwei Chen has been recognized with two Science and Technology Progress Awards by the Chinese PLA, highlighting her contributions to national health security and research excellence. Her leadership in international medical missions, particularly in Sierra Leone during the COVID-19 crisis, earned her high praise from the Sierra Leone Armed Forces. These honors underscore her commitment to public health, international collaboration, and the advancement of medical science in service of military and civilian populations alike.

Publication

Chen has published over 80 academic papers, including 17 in SCI-indexed journals. Selected key publications include:

  1. Immune profiling in severe COVID-19 patients (2020), Science Translational Medicine, cited by 350 articles.

  2. Clinical features of adenovirus pneumonia outbreaks (2021), Journal of Infection, cited by 112 articles.

  3. Pathogen detection using multiplex PCR in military cohorts (2022), Frontiers in Microbiology, cited by 75 articles.

  4. Strategies for laboratory biosafety in pandemic response (2019), Military Medical Research, cited by 63 articles.

  5. Comparative study on antiviral treatments in influenza (2021), Virology Journal, cited by 58 articles.

  6. Field diagnostics innovation during Ebola resurgence (2020), Tropical Medicine and Health, cited by 49 articles.

  7. Adjuvant therapy targets in viral pneumonia (2023), International Journal of Infectious Diseases, cited by 37 articles.
    These works collectively reflect her expertise in virology, diagnostic innovation, and field medicine.

Conclusion

Weiwei Chen’s professional journey exemplifies dedication to the advancement of infectious disease research, diagnostics, and international cooperation in public health emergencies. Her educational achievements, research contributions, and field leadership mark her as a pivotal figure in medical science, particularly in the strategic domains of epidemic preparedness and military medicine. Through a career characterized by scientific rigor and humanitarian service, she continues to impact global health security and stands as a compelling nominee for any award honoring excellence in infectious disease research and public health.